Health

Why We Are Hopeful About Improving Health In Africa

Published

8 years ago

25/04/2017

By Aliko Dangote and Bill Gates

This week, more than 138,000 vaccinators will fan out across five African countries in the Lake Chad area in a push to eliminate polio in Africa and rid the world of this terrible disease forever.

They will take boats across fast-flowing rivers, ride jeeps along sandy ravines, walk crowded street in towns and cities and navigate cramped quarters of refugee camps to ensure that every child is immunized.

Traveling for hours a day, these dedicated women and men will visit children in homes, schools, train stations, and transit points across Nigeria, Niger, Chad, Cameroon, and the Central African Republic.

This also marks World Immunization Week, a coordinated effort to make sure that people everywhere understand the importance of getting immunized to protect against vaccine-preventable diseases.

And by coincidence, it was almost seven years ago that the two of us first met in a hotel conference room in Abuja, Nigeria’s capital. We were there as part of a diverse group—public officials, religious leaders, business people, polio survivors, and journalists—to discuss how we could work together to stop polio in Nigeria.

At the time, Nigeria had done an amazing job tackling polio—reducing reported cases by 95 percent in just one year. But it was still circulating in six Nigerian states. While 95 percent might seem like success, as long as a single child remains infected, children across Africa and around the world are at risk.

Thanks to the effort of so many, Nigeria’s Borno State is now the only place in Africa today where polio is still circulating. It will take ingenuity to end polio there, and it will take persistence to continue reaching children in the surrounding area with vaccines to protect them from the disease until it is eradicated. But we’re confident it can be done. And when that happens, Africa will celebrate one of the biggest victories ever in public health.

Since our first meeting in 2010, the two of us have worked together on a range of other projects to help improve health in Nigeria and across Africa.

We supported the establishment of emergency operations centers in Nigeria and other countries to keep polio from spreading. This turned out to be a blessing during the 2014 Ebola outbreak in West Africa. When the disease first appeared in Nigeria—an international travel hub that is home to more than 180 million people—the staff of an emergency operations center set up in Lagos jumped into action and stopped the disease in its tracks. It’s almost unimaginable to think what would have happened without them.

In the state of Kano, we are working with the government to ensure that children can get essential childhood immunizations against tetanus, pneumonia, liver cancer and measles. And when parents bring their children into a clinic for vaccinations, health workers can address other health issues, too, like nutrition, care for pregnant mothers and newborns and malaria prevention and treatment. We have since widened the program to several other states.

Vaccines are also one of the best tools to save lives in an epidemic, such as the meningitis C outbreak happening now in Nigeria and other West African countries.

And because of the devastating impact malnutrition has on Nigeria’s children – leading to 300,000 deaths annually and causing stunted growth and development in millions more – we have expanded our partnership to include nutrition programs across 12 states.

Earlier this year, we also helped launch the End Malaria Council, a group of influential public and private sector leaders committed to ensuring that malaria eradication remains a top global priority.

Underlying all these efforts is our belief that strengthening health systems is the key to breaking the cycle of extreme poverty and disease—and kick-starting a virtuous cycle of health, productivity, and prosperity.

In our work together, we have learned a few important lessons.

First, improving the health of communities depends on a successful partnership between government, communities, religious and business leaders, volunteers, and NGOs. This ensures that everyone is rowing in the same direction. And it is essential to building trust so parents have the confidence that vaccines are safe and will protect their children from life-threatening diseases.

Second, we must keep innovating to speed up progress. This month, for example, vaccinators will test a new vaccine carrier that keeps the temperature of vaccines stable for up to five days, even in blistering heat. This breakthrough will enable vaccinators to finally reach children in extremely remote areas with life-saving vaccines.

Last, accurate and reliable data is central to any effort to improve health. Data can tell a health officer which communities are running low on vaccine supplies, where there are gaps in vaccination coverage, and which new mothers need reminders to take their babies to the health clinic to be immunized.

An Africa without polio is within reach. So is the vision of getting life-saving vaccines to every child. Success will generate more enthusiasm and support from across different sectors – government, business, civil society, the media – to tackle other killer diseases and the underlying conditions that affect people’s health, including fixing broken health systems.

We know that strengthening health systems takes time and diligence. We are optimistic that Africa can achieve the future it aspires to. That future depends on people working together—across national borders and across socioeconomic strata—to build the better world we all want.

This is an opinion piece by Aliko Dangote and Bill Gates

Health

FG Begins Vaccination Against Mpox in FCT, Six States

Published

2 weeks ago

19/11/2024

Adedapo Adesanya

By Adedapo Adesanya

The Federal Ministry of Health and Social Welfare through the National Primary Health Care Development Agency (NPHCDA) has commenced the vaccination against Monkeypox, now known as Mpox.

Business Post reports that Bayelsa, Rivers, Cross River, Akwa Ibom, Enugu, Benue, and the Federal Capital Territory, were selected as pilot states for the vaccination.

An average of 631 persons are expected to be vaccinated across the seven states with two doses of the Mpox vaccine. A buffer for 50 persons will be kept at the national in case of an upsurge in other states.

NPHCDA in a statement posted on its verified X account confirmed the exercise, stressing that the vaccination will help to protect communities and safeguarding health of the people.

In a related development, according to the latest update by the Nigeria Centre for Disease Control (NCDC), there are 1,442 suspected cases of Mpox from 36 states and the Federal Capital Territory, while the number of confirmed cases of the infection was 118 from 28 states and the FCT.

“To prevent the spread of Mpox, we strongly advise the public to avoid contact with animals that may carry the virus, including sick or dead animals in affected areas, avoid handling materials that have been in contact with infected animals, limit unnecessary physical contact with individuals who are infected, practice frequent handwashing with soap and water, and ensure that animal food products are thoroughly cooked before eating.

“It’s also important to use protective clothing and gloves when handling sick animals or their tissues. Similarly, health workers are advised to follow standard safety protocols including droplet precautions when treating patients, use protective equipment including masks, gloves, and gowns, during patient care, and be vigilant for symptoms of Mpox, especially fever and rash, among other measures.”

Health

AXA Mansard Health Partners LUTH in Blood Donation Drive

Published

2 weeks ago

14/11/2024

Aduragbemi Omiyale

By Aduragbemi Omiyale

Over 250 pints of blood have been donated by AXA Mansard Health to the Lagos University Teaching Hospital (LUTH), Idi Araba.

The blood was donated by more than 100 employees of the leading health insurance company in Nigeria through its volunteering programme tagged AXA Hearts in Action.

The initiative is part of the company’s blood donation drive aimed at contributing to positive societal and environmental impacts through employee volunteering, and expertise related financial support and in-kind donations.

According to the Chief Client Officer of AXA Mansard, Ms Rashidat Adebisi, “Through the AHIA, our employees do not just give time to great causes; we work together for a better future.”

“We share our time, knowledge and expertise as a people with a shared purpose of acting for human progress by protecting what matters through initiatives like this,” she added.

Ms Adebisi said the blood drive is a shining example of the philosophy in action, where collective contributions serve as a reminder that true impact often involves giving more than just money. It’s about putting one’s heart in action – an idea embedded in AXA’s corporate culture.

On his part, the chief executive of AXA Mansard Health Limited, Mr Tope Adeniyi, said with hospitals frequently experiencing blood shortages, events like these serve as a lifeline for patients in need.

“We are proud to contribute to the local healthcare sector and provide much-needed support to hospitals such as LUTH, ensuring that they have resources essential to saving lives,” he added.

Also commenting, the Head of Corporate Services and Public Relations at LUTH, Omolola Olubukunola Fakeye, thanked the firm for the “generous support,” which has made a “meaningful difference to our blood bank and ultimately to the lives of patients.”

“Blood donations are invaluable in many critical treatments, and initiatives like AXA Mansard’s blood drive bring immense relief to healthcare system.

“We are sincerely grateful for this partnership and the dedication of AXA Mansard’s employees,” Fakeye stated.

AXA Hearts in Action operates globally, she urging AXA employees everywhere to engage with and give back to their communities.

Through diverse projects – from health initiatives like this blood drive and medical outreaches to environmental efforts like the AXA Week for Good “Trash-to-Treasure” waste management project – AXA staff have opportunities to make a lasting difference on issues that matter.

For AXA Mansard, every act of social service brings them closer to the communities they serve, helping build a world where giving back is not only about charity but about lasting, positive change.

Health

US Buys 4.8 million Swipha Malaria Doses for Nigeria, Others

Published

2 weeks ago

13/11/2024

Adedapo Adesanya

By Adedapo Adesanya

The US Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that will expand access to essential medicines in Nigeria and West Africa.

This procurement, to be facilitated through the U.S. Government’s President’s Malaria Initiative (PMI), underscores the United States’ dedication to advancing Nigeria’s healthcare infrastructure and ensuring life-saving treatments reach vulnerable communities.

For years, Nigeria has faced significant challenges in procuring affordable, high-quality medicines due to the high cost of production and the inability of many local pharmaceutical companies to meet international quality standards.

According to the World Health Organization (WHO), fewer than 10 per cent of medicines manufactured in sub-Saharan Africa meet global standards, limiting local companies’ ability to supply essential drugs and meet healthcare needs.

These barriers have particularly affected access to medicines for malaria and child health, as local production has often fallen short of both quality and quantity requirements.

In response, USAID partnered with Swipha in their efforts to attain World Health Organization (WHO) prequalification for sulfadoxine/pyrimethamine (SP) tablets, a vital medicine for malaria prevention during pregnancy.

Swipha is now the first pharmaceutical company in Nigeria and in West Africa to achieve this WHO certification, marking a critical step forward for the region’s pharmaceutical capacity.

“USAID’s support was pivotal in helping us reach this milestone,” said Swipha Managing Director, Mr Frederic Lieutaud.

“The WHO prequalification not only validates our commitment to producing high-quality medicines but also enhances our capacity to scale production and serve both local and international markets with trusted, essential medicines.”

With the WHO prequalification, Swipha is well-positioned to expand its reach, supplying these essential medicines to international donors and procurement agencies, ultimately strengthening healthcare delivery across Nigeria and the broader West African region.

This achievement also represents a significant boost to Nigeria’s healthcare system by enhancing local manufacturing capacity and contributing to public health efforts to combat preventable diseases.

During her visit to Swipha’s facility in Lagos, USAID Mission Director to Nigeria, Ms Melissa Jones, commented “This achievement is a testament to the power of collaboration in improving healthcare in Nigeria.

“We are proud to have supported Swipha in reaching this milestone and look forward to continuing our partnership to ensure more quality medicines reach those who need them most. Together, we are building a healthier future for Nigeria.”